Something to consider

Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fairchijisback

Rank: President [?]

Points: 73381 [?]

Votes: 478 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Something to consider

posted on Feb 26, 2019 07:55PM

Here is something to think about when we think of investing in very high impact high risk ventures. For the record I don’t consider POETs current situation as high risk but many do or profess to.

PROMETIC LIFE SCIENCES…ticker PLI is a biotech that has been around for very long time with some really high impact drugs in the pipeline. They burn about $100 million a year in R&D. The CEO just retired after some 25 years.

They have 750million shares outstanding and have extended the maturity date on a $100 million loan facility.

So Monday they announced that they have secured another USD$10 million tranche from the existing loan facility.

The stock moved up .07 over the last 2 days adding some $50 million to the market cap of the company after announcing $10 million in funding.

That is about half of the existing valuation of POET. Makes you wonder what impact new funding to bridge the next few months will have on POETs share price leading to $40million when DenseLight is sold.